St. Jude Medical Company Profile (NYSE:STJ)

About St. Jude Medical

St. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. The Company's product categories include tachycardia implantable cardioverter defibrillator systems; atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems); bradycardia pacemaker systems; vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring devices and other vascular accessories); structural heart products (heart valve replacement and repair products and structural heart defect devices); neuromodulation products, and Thoratec products.

Industry, Sector and Symbol:

Sector: Medical
Industry: Medical Appliances & Equipment
Sub-Industry: Health Care Equipment
Exchange: NYSE
Symbol: STJ
CUSIP: 79084910

Key Metrics:

Previous Close: $79.73
50 Day Moving Average: $80.28
200 Day Moving Average: $73.95
52-Week Range: $48.83 - $84.00
Trailing P/E Ratio: 34.67
Foreward P/E Ratio: 18.04
P/E Growth: 1.72
Market Cap: $22.72B
Outstanding Shares: 284,929,000
Beta: 1.32

Profitability:

Net Margins: 11.40%
Return on Equity: 27.60%
Return on Assets: 9.17%

Debt:

Debt-to-Equity Ratio: 1.27%
Current Ratio: 1.71%
Quick Ratio: 1.18%

Additional Links:

Companies Related to St. Jude Medical:

Consensus Ratings for St. Jude Medical (NYSE:STJ) (?)

Ratings Breakdown:	19 Hold Ratings, 5 Buy Ratings
Consensus Rating:	Hold (Score: 2.21)
Consensus Price Target:	$74.08 (7.09% downside)

Analysts' Ratings History for St. Jude Medical (NYSE:STJ)

Show:

Date	Firm	Action	Rating	Price Target
9/12/2016	Jefferies Group	Reiterated Rating	Hold	$60.00
8/28/2016	Argus	Reiterated Rating	Hold
8/28/2016	Credit Suisse Group AG	Reiterated Rating	Neutral	$81.00
8/15/2016	Barclays PLC	Reiterated Rating	Equal Weight	$83.00
7/20/2016	Canaccord Genuity	Set Price Target	Hold	$85.00
7/21/2016	Leerink Swann	Reiterated Rating	Hold	$85.00
7/17/2016	JPMorgan Chase & Co.	Reiterated Rating	Hold
7/15/2016	Wedbush	Downgrade	Outperform -> Neutral	$70.00 -> $84.00
5/10/2016	SunTrust Banks Inc.	Downgrade	Buy -> Neutral	$70.00 -> $80.00
5/2/2016	Morgan Stanley	Downgrade	Overweight -> Equal Weight	$67.00 -> $81.00
4/30/2016	Wells Fargo & Co.	Reiterated Rating	Hold
4/29/2016	William Blair	Downgrade	Outperform -> Market Perform
4/29/2016	Needham & Company LLC	Downgrade	Buy -> Hold
4/28/2016	Piper Jaffray Cos.	Downgrade	Overweight -> Neutral
4/18/2016	BTIG Research	Downgrade	Buy -> Neutral
4/15/2016	Bank of America Corp.	Reiterated Rating	Buy	$66.00
3/28/2016	Oppenheimer Holdings Inc.	Boost Price Target	Market Perform	$57.00 -> $67.00
3/28/2016	Cowen and Company	Upgrade	Market Perform -> Outperform	$66.00 -> $73.00
3/28/2016	BMO Capital Markets	Boost Price Target	Outperform	$66.00 -> $73.00
3/16/2016	Nomura	Initiated Coverage	Buy	$64.00
1/25/2016	Royal Bank Of Canada	Lower Price Target	Sector Perform	$66.00 -> $57.00
1/15/2016	Deutsche Bank AG	Lower Price Target	Hold	$65.00 -> $64.00
1/4/2016	Sterne Agee CRT	Lower Price Target	Buy	$81.00 -> $78.00
10/22/2015	Stifel Nicolaus	Downgrade	Buy -> Hold
9/1/2015	Evercore ISI	Reiterated Rating	Hold	$80.00
8/28/2015	S&P Equity Research	Reiterated Rating	Buy	$92.00
1/29/2015	CRT Capital	Lower Price Target	Buy	$80.00 -> $78.00

(Data available from 9/28/2014 forward)

Earnings History for St. Jude Medical (NYSE:STJ)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/19/2016
7/20/2016	Q216	$1.06	$1.06	$1.55 billion	$1.56 billion	View	Listen
4/20/2016	Q116	$0.88	$0.90	$1.43 billion	$1.45 billion	View	Listen
1/27/2016	Q415	$1.01	$1.02	$1.48 billion	$1.45 billion	View	Listen
10/21/2015	Q315	$0.97	$0.97	$1.35 billion	$1.34 billion	View	Listen
7/22/2015	Q215	$1.00	$1.03	$1.39 billion	$1.41 billion	View	Listen
4/22/2015	Q115	$0.91	$0.93		$1.35 billion	View	N/A
1/28/2015	Q414	$1.03	$1.03	$1.44 billion	$1.44 billion	View	N/A
10/15/2014	Q314	$0.96	$0.97	$1.39 billion	$1.38 billion	View	Listen
7/16/2014	Q214	$1.00	$1.02	$1.44 billion	$1.45 billion	View	N/A
4/16/2014	Q114	$0.95	$0.96	$1.36 million	$1.36 million	View	N/A
1/22/2014	Q413	$0.97	$0.99	$1.38 billion	$1.42 billion	View	Listen
10/16/2013	Q313	$0.89	$0.90	$1.32 billion	$1.34 billion	View	Listen
7/17/2013	Q2 2013	$0.94	$0.96	$1.36 billion	$1.40 billion	View	Listen
4/17/2013	Q1 2013	$0.91	$0.92	$1.36 billion	$1.34 billion	View	Listen
1/23/2013	Q4 2012	$0.87	$0.92	$1.37 billion	$1.37 billion	View	Listen
10/17/2012		$0.81	$0.83			View	N/A
7/18/2012		$0.87	$0.86			View	N/A
4/18/2012		$0.83	$0.86			View	N/A
1/25/2012		$0.84	$0.86			View	N/A
10/19/2011		$0.76	$0.78			View	N/A
7/20/2011		$0.84	$0.85			View	N/A
4/20/2011		$0.78	$0.80			View	N/A
1/26/2011		$0.74	$0.75			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for St. Jude Medical (NYSE:STJ)

Current Year EPS Consensus Estimate: $4.06 EPS
Next Year EPS Consensus Estimate: $4.42 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	6	$0.88	$1.04	$0.92
Q2 2016	7	$0.99	$1.13	$1.05
Q3 2016	6	$0.98	$1.03	$1.01
Q4 2016	8	$1.06	$1.11	$1.08
Q1 2017	7	$0.98	$1.16	$1.03
Q2 2017	6	$1.08	$1.25	$1.16
Q3 2017	5	$1.09	$1.16	$1.12
Q4 2017	6	$1.15	$1.24	$1.20

(Data provided by Zacks Investment Research)

Current Dividend Information for St. Jude Medical (NYSE:STJ)

Annual Dividend:	$1.24
Dividend Yield:	1.56%
Dividend Growth:	8.20% (3 Year Average)
Payout Ratio:	53.91% (Based on Trailing 12 Months of Earnings) 30.54% (Based on Current Year Consensus EPS Estimate) 28.05% (Based on Next Year Consensus EPS Estimate)
Track Record:	5 Years of Consecutive Dividend Growth

Dividend History for St. Jude Medical (NYSE:STJ)

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/3/2016	quarterly	$0.31	1.49%	9/28/2016	9/30/2016	10/28/2016
5/4/2016	quarterly	$0.31	1.64%	6/28/2016	6/30/2016	7/29/2016
2/19/2016	quarterly	$0.31	2.3%	3/29/2016	3/31/2016	4/29/2016
12/7/2015	quarterly	$0.29	1.9%	12/29/2015	12/31/2015	1/29/2016
8/4/2015	quarterly	$0.29	1.58%	9/28/2015	9/30/2015	10/30/2015
5/6/2015	quarterly	$0.29	1.63%	6/26/2015	6/30/2015	7/31/2015
2/20/2015	quarterly	$0.29	1.69%	3/27/2015	3/31/2015	4/30/2015
10/21/2014	quarterly	$0.27	1.81%	12/29/2014	12/31/2014	1/30/2015
7/29/2014	quarterly	$0.27	1.62%	9/26/2014	9/30/2014	10/31/2014
5/1/2014	quarterly	$0.27	1.71%	6/26/2014	6/30/2014	7/31/2014
2/24/2014	quarterly	$0.27	1.6%	3/27/2014	3/31/2014	4/30/2014
12/9/2013	quarterly	$0.25	1.68%	12/27/2013	12/31/2013	1/31/2014
7/30/2013	quarterly	$0.25	1.91%	9/26/2013	9/30/2013	10/31/2013
5/1/2013	quarterly	$0.25	2.46%	6/26/2013	6/28/2013	7/31/2013
2/25/2013	quarterly	$0.25	2.45%	3/26/2013	3/29/2013	4/30/2013
12/11/2012	quarterly	$0.23	2.59%	12/27/2012	12/31/2012	1/31/2013

(Data available from 1/1/2013 forward)

Insider Trading History for St. Jude Medical (NYSE:STJ)

Insider Ownership Percentage: 4.80%
Institutional Ownership Percentage: 81.78%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
2/5/2016	Jeff Fecho	VP	Sell	10,408	$51.71	$538,197.68
12/21/2015	Donald Zurbay	CFO	Sell	3,106	$60.96	$189,341.76
12/21/2015	Jeff Dallager	VP	Sell	501	$60.94	$30,530.94
12/18/2015	John C Heinmiller	EVP	Sell	8,009	$61.16	$489,830.44
10/28/2015	Daniel J. Starks	CEO	Sell	120,000	$62.36	$7,483,200.00
4/28/2015	Daniel J Starks	CEO	Sell	100,000	$72.46	$7,246,000.00
4/27/2015	Mark W Murphy	VP	Sell	5,882	$72.45	$426,150.90
4/24/2015	Jason Zellers	VP	Sell	3,566	$74.13	$264,347.58
4/24/2015	Joel Becker	Insider	Sell	17,870	$73.87	$1,320,056.90
4/24/2015	John C Heinmiller	EVP	Sell	160,000	$73.69	$11,790,400.00
4/24/2015	Lisa Andrade	CMO	Sell	5,000	$73.87	$369,350.00
4/24/2015	Stuart Essig	Director	Sell	7,750	$73.85	$572,337.50
4/22/2015	I Paul Bae	VP	Sell	34,000	$73.00	$2,482,000.00
4/22/2015	Lisa Andrade	CMO	Sell	5,000	$70.55	$352,750.00
2/10/2015	Michael A Rocca	Director	Sell	3,875	$65.57	$254,083.75
2/6/2015	Michael T Rousseau	COO	Sell	7,207	$67.31	$485,103.17
2/3/2015	Denis M Gestin	Insider	Sell	148,500	$67.13	$9,968,805.00
2/3/2015	Scott Thome	VP	Sell	6,666	$67.94	$452,888.04
2/2/2015	Mark W Murphy	VP	Sell	859	$66.92	$57,484.28
2/2/2015	Richard R Devenuti	Director	Sell	7,750	$66.43	$514,832.50
12/18/2014	John C Heinmiller	EVP	Sell	6,853	$64.60	$442,703.80
10/27/2014	Jeff Fecho	VP	Sell	500	$60.55	$30,275.00
10/23/2014	Jason Zellers	VP	Sell	33,999	$60.04	$2,041,299.96
10/22/2014	Daniel J Starks	CEO	Sell	100,000	$60.04	$6,004,000.00
7/30/2014	Mark Carlson	VP	Sell	1,198	$66.40	$79,547.20
7/29/2014	Daniel J Starks	CEO	Sell	90,000	$66.25	$5,962,500.00
7/29/2014	Mark W Murphy	VP	Sell	2,000	$66.43	$132,860.00
7/28/2014	Denis M Gestin	Insider	Sell	99,000	$66.76	$6,609,240.00
7/28/2014	Rachel Ellingson	VP	Sell	2,630	$66.72	$175,473.60
7/18/2014	Scott Thome	VP	Sell	5,997	$67.06	$402,158.82
2/6/2014	Michael Rocca	Director	Sell	5,600	$60.36	$338,016.00
2/5/2014	Scott Thome	VP	Sell	7,500	$59.57	$446,775.00
2/4/2014	Michael Rousseau	COO	Sell	4,644	$59.76	$277,525.44
1/27/2014	Jeff Fecho	VP	Sell	10,408	$61.28	$637,802.24
1/27/2014	Joel Becker	Insider	Sell	14,164	$61.58	$872,219.12
1/24/2014	Mark Murphy	VP	Sell	9,480	$63.14	$598,567.20
12/18/2013	Joel Becker	Insider	Sell	37,916	$59.54	$2,257,518.64
12/18/2013	John Heinmiller	EVP	Sell	4,144	$59.49	$246,526.56
12/16/2013	Frank Callaghan	Insider	Sell	73,826	$59.28	$4,376,405.28
12/9/2013	Daniel Starks	CEO	Sell	108,000	$59.41	$6,416,280.00
11/5/2013	Daniel Starks	CEO	Sell	108,000	$57.33	$6,191,640.00
10/31/2013	Michael T Rousseau	Insider	Sell	50,000	$57.81	$2,890,500.00
10/29/2013	Kathy Chester	VP	Sell	9,375	$58.12	$544,875.00
10/29/2013	Michael T Rousseau	Insider	Sell	50,000	$57.76	$2,888,000.00
10/28/2013	Donald Zurbay	CFO	Sell	40,000	$57.31	$2,292,400.00
10/28/2013	Mark W Murphy	VP	Sell	5,024	$57.51	$288,930.24
10/25/2013	Jason Zellers	VP	Sell	14,917	$57.15	$852,506.55
10/24/2013	Joel Becker	Insider	Sell	9,613	$56.48	$542,942.24
10/23/2013	John C Heinmiller	EVP	Sell	150,000	$56.48	$8,472,000.00
10/23/2013	Kathy Chester	VP	Sell	20,000	$56.50	$1,130,000.00
10/22/2013	Angela D Craig	VP	Sell	24,402	$56.59	$1,380,909.18
10/21/2013	Frank J Callaghan	Insider	Sell	133,096	$56.26	$7,487,980.96
10/21/2013	Mark W Murphy	VP	Sell	3,930	$56.26	$221,101.80
10/18/2013	Jason Zellers	VP	Sell	10,916	$56.56	$617,408.96
10/18/2013	Michael T Rousseau	Insider	Sell	61,000	$56.65	$3,455,650.00
10/18/2013	Wendy L Yarno	Director	Sell	22,150	$56.50	$1,251,475.00
10/4/2013	Denis Gestin	Insider	Sell	137,000	$55.25	$7,569,250.00
10/4/2013	Donald Zurbay	CFO	Sell	12,000	$55.55	$666,600.00
9/11/2013	Mark Murphy	VP	Sell	4,200	$53.50	$224,700.00
8/9/2013	Angela Craig	VP	Sell	13,600	$54.00	$734,400.00
8/9/2013	Frank Callaghan	Insider	Sell	11,000	$54.00	$594,000.00
7/29/2013	Jason Zellers	VP	Sell	10,359	$52.22	$540,946.98
7/29/2013	Stuart Essig	Director	Sell	5,600	$52.19	$292,264.00
7/25/2013	Kathy Chester	VP	Sell	16,250	$52.00	$845,000.00
7/22/2013	Jason Zellers	VP	Sell	7,341	$51.91	$381,071.31
7/19/2013	Donald Zurbay	CFO	Sell	50,000	$51.28	$2,564,000.00
7/19/2013	Jeff Fecho	VP	Sell	13,848	$50.82	$703,755.36
7/19/2013	Joel Becker	Insider	Sell	11,700	$50.50	$590,850.00
5/2/2013	Richard R Devenuti	Director	Sell	5,270	$40.64	$214,172.80
2/5/2013	Denis M Gestin	Insider	Sell	90,000	$41.32	$3,718,800.00
2/5/2013	Thomas R Northenscold	VP	Sell	22,000	$41.40	$910,800.00
10/25/2012	John W Brown	Director	Buy	25,000	$38.65	$966,250.00

(Data available from 1/1/2013 forward)

Latest Headlines for St. Jude Medical (NYSE:STJ)

Date	Headline
	Pay Close Attention To These Analyst Ratings Hilton Worldwide Holdings Inc (NYSE:HLT), St. Jude Medical, Inc ... - The Voice Registrar (NYSE:STJ) voiceregistrar.com - September 28 at 7:14 PM
	St. Jude Medical, Inc. (NYSE:STJ):Consensus Rating At 2.89 - Investor Newswire (NYSE:STJ) www.investornewswire.com - September 28 at 12:17 PM
	Mediation Talks Between Abbott and Alere Collapse (NYSE:STJ) www.thestreet.com - September 28 at 11:56 AM
	Today's Top Gainers in the Market St. Jude Medical Inc. (NYSE:STJ) from Healthcare - The Daily Leicester (NYSE:STJ) thedailyleicester.com - September 27 at 12:06 PM
	Can Shares Of St. Jude Medical, Inc. (NYSE:STJ) Hit $89? - Investor Newswire (NYSE:STJ) www.investornewswire.com - September 26 at 7:32 PM
	Home Finance Earnings Reaction History: St. Jude Medical Inc. (NYSE:STJ) has a 51.85% chance... - The Independent Republic (NYSE:STJ) theindependentrepublic.com - September 26 at 7:32 PM
	Analysts Valuations For Two Stocks: St. Jude Medical, Inc. (NYSE:STJ), Phillips 66 (NYSE:PSX) - The Voice Registrar (NYSE:STJ) voiceregistrar.com - September 26 at 7:32 PM
	Today's Top Gainers in the Market St. Jude Medical Inc. (NYSE:STJ ... - The Daily Leicester (NYSE:STJ) thedailyleicester.com - September 24 at 6:43 PM
	A look at a High Market Cap Stock: St. Jude Medical Inc., STJ - The Daily Leicester (NYSE:STJ) thedailyleicester.com - September 22 at 7:06 PM
	Stocks in Frontline Trades' Choice: Medivation, Inc. (NASDAQ:MDVN), St. Jude Medical Inc. (NYSE:STJ) - Street Wise Report (press release) (blog) (NYSE:STJ) streetwisereport.com - September 22 at 7:06 PM
	St. Jude Medical, Inc. (NYSE:STJ) Had $667 In Cash And Short-Term Investments - Stocks Daily (NYSE:STJ) www.stocksdaily.net - September 22 at 7:06 PM
	St. Jude Medical Inc.'s (STJ): Stock's Financial Statistics - Hot Stocks ... - Hot Stocks Point (NYSE:STJ) www.hotstockspoint.com - September 21 at 7:01 PM
	St Jude Medical : Assigned Patent (NYSE:STJ) www.4-traders.com - September 21 at 11:37 AM
	46.5% Return Seen to Date on SmarTrend St Jude Medical Call (STJ) (NYSE:STJ) www.mysmartrend.com - September 19 at 7:26 PM
	High Market Cap Stock of the Day – St. Jude Medical Inc. (NYSE:STJ) (NYSE:STJ) twincountynews.com - September 19 at 7:26 PM
	St. Jude Medical’s Stock Prices Are on a Declining Trend (NYSE:STJ) marketrealist.com - September 19 at 11:42 AM
	Is St. Jude Medical Inc. (NYSE:STJ), a large market cap stock a smart buy? (NYSE:STJ) twincountynews.com - September 17 at 11:20 AM
	Abbott to sell its eye care business to J&J for about $4.33 billion - Yahoo Finance (NYSE:STJ) finance.yahoo.com - September 16 at 7:11 PM
	Trial Progression of St. Jude Medical's Stroke Prevention Device - Market Realist (NYSE:STJ) marketrealist.com - September 16 at 7:11 PM
	Pay Close Attention To These Analyst Ratings Lowe's Companies, Inc. (NYSE:LOW), St. Jude Medical, Inc. (NYSE:STJ) - The Voice Registrar (NYSE:STJ) voiceregistrar.com - September 15 at 7:35 PM
	St Jude Medical : Federal Contracts Awarded to Companies in Minnesota (Sept. 14) (NYSE:STJ) www.4-traders.com - September 14 at 7:40 PM
	HC Stocks Overview= Mylan NV (NASDAQ:MYL), St. Jude Medical ... - share market updates (press release) (NYSE:STJ) sharemarketupdates.com - September 14 at 11:50 AM
	Analysts Valuations For Two Stocks: St. Jude Medical, Inc. (NYSE:STJ), Gilead Sciences, Inc. (NASDAQ:GILD) - The Voice Registrar (NYSE:STJ) voiceregistrar.com - September 14 at 11:50 AM
	St. Jude Medical Inc. (NYSE: STJ) Hold Rating Reiterated at Jefferies Group - BNB Daily (blog) (NYSE:STJ) www.baseball-news-blog.com - September 14 at 11:50 AM
	Chance of St. Jude recall over cybersecurity threat 'practically zero ... - Minneapolis / St. Paul Business Journal (NYSE:STJ) www.bizjournals.com - September 13 at 11:39 AM
	HC Stocks Highlights= Celgene Corporation (CELG), St. Jude Medical, Inc. (NYSE:STJ) - share market updates (press release) (NYSE:STJ) sharemarketupdates.com - September 13 at 11:39 AM
	Chance of St. Jude recall over cybersecurity threat 'practically zero,' analyst says (NYSE:STJ) www.bizjournals.com - September 12 at 7:01 PM
	St. Jude Medical Inc. (NYSE:STJ) from Medical Appliances & Equipment – Todays Top Gains (NYSE:STJ) twincountynews.com - September 12 at 11:30 AM
	Can Abbott Labs Find a Cure for Its Ailing Shares? (NYSE:STJ) www.thestreet.com - September 12 at 11:30 AM
	Jefferies Cautions Investors: St. Jude Medical Device Issue Not Over Yet - Benzinga (NYSE:STJ) www.benzinga.com - September 11 at 11:23 AM
	St. Jude Medical Sues Muddy Waters (NYSE:STJ) www.nasdaq.com - September 9 at 7:05 PM
	St Jude Medical Has Returned 45.2% Since SmarTrend Recommendation (STJ) (NYSE:STJ) www.mysmartrend.com - September 9 at 7:05 PM
	St. Jude Files Lawsuit Over Medical Device Security Claims (NYSE:STJ) healthitsecurity.com - September 9 at 7:05 PM
	New Long-Term Data Reaffirm the Benefits of Medtronic’s Micra TPS (NYSE:STJ) marketrealist.com - September 9 at 7:05 PM
	Jefferies Cautions Investors: St. Jude Medical Device Issue Not Over Yet (NYSE:STJ) feeds.benzinga.com - September 9 at 3:48 PM
	St. Jude Medical, Inc. (NYSE:STJ) From The Analysts Point of View (NYSE:STJ) www.nationaldailypress.com - September 9 at 11:20 AM
	US health regulator plans 'thorough' probe of St. Jude case (NYSE:STJ) www.foxnews.com - September 9 at 11:20 AM
	St. Jude Medical sues short seller Muddy Waters (NYSE:STJ) www.marketwatch.com - September 8 at 7:09 PM
	St. Jude lawsuit: Muddy Waters-MedSec report is false, manipulative (NYSE:STJ) www.fiercehealthcare.com - September 8 at 7:09 PM
	INTERVIEW-U.S. health regulator plans 'thorough' probe of St Jude case (NYSE:STJ) www.cnbc.com - September 8 at 7:09 PM
	Analysts Valuations For Two Stocks: St. Jude Medical, Inc. (NYSE:STJ), Citizens Financial Group Inc (NYSE:CFG) - The Voice Registrar (NYSE:STJ) voiceregistrar.com - September 8 at 11:22 AM
	St. Jude Medical Sues Short Seller Over Device Allegations - Wall Street Journal (NYSE:STJ) www.wsj.com - September 8 at 11:22 AM
	RPT-St. Jude's lawsuit against short-seller faces steep climb -lawyers (NYSE:STJ) feeds.reuters.com - September 8 at 8:41 AM
	St. Jude sues short-seller, cyber security firm (NYSE:STJ) www.bizjournals.com - September 7 at 7:37 PM
	St. Jude's lawsuit against short-seller faces steep climb -lawyers (NYSE:STJ) finance.yahoo.com - September 7 at 7:37 PM
	St. Jude's lawsuit against short-seller faces steep climb: lawyers (NYSE:STJ) sg.finance.yahoo.com - September 7 at 7:37 PM
	St. Jude Medical Files Lawsuit Against Muddy Waters And MedSec - Quick Facts (NYSE:STJ) www.nasdaq.com - September 7 at 11:11 AM
	Medical Supplier St. Jude Is Suing Short Seller Muddy Waters (NYSE:STJ) fortune.com - September 7 at 11:11 AM
	St. Jude Medical Files Lawsuit Against Muddy Waters (NYSE:STJ) www.bloomberg.com - September 7 at 11:11 AM
	St. Jude Medical Sues Short Seller Over Device Allegations (NYSE:STJ) www.wsj.com - September 7 at 11:11 AM